GlassScriptPhysician profile
James A Nobles
NPI 1245340587
$4,959.87
in general payments reported to CMS, 2019-2025
18 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.37 · 2021: $195 · 2022: $238 · 2023: $4,299 · 2024: $79.92 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,094 · Travel and Lodging: $1,021 · Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,094.00 |
| Travel and Lodging | $1,020.77 |
| Food and Beverage | $394.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,081.08 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $159.78 | 2021-2024 | |
| Astellas Pharma US INC | $154.45 | 2023-2024 | Veozah, Myrbetriq |
| Lundbeck LLC | $111.61 | 2021 | |
| Amgen INC. | $81.30 | 2021-2023 | Evenity, Prolia |
| Aspira Women'S Health INC | $50.07 | 2021 | |
| Shield Therapeutics INC | $45.20 | 2023 | Accrufer |
| Takeda Pharmaceuticals U.S.A., INC. | $39.82 | 2022 | |
| Innovation Technologies INC | $31.28 | 2025 | Irrisept |
| Convatec INC. | $30.57 | 2023 | |
| Biotissue Holdings INC. | $28.45 | 2025 | |
| Sage Therapeutics, LLC | $27.01 | 2025 | Zurzuvae |
| Organon LLC | $26.11 | 2025 | Jada System |
| Smith+Nephew, INC. | $22.34 | 2024 | Pico 7 |
| Agile Therapeutics, INC. | $19.29 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.37 | 2019 | |
| Pfizer INC. | $16.81 | 2022 | |
| Hologic Sales and Service, LLC | $16.33 | 2024 | Myosure Tissue Removal Device, Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Nobles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.